Decrease of cyclic GMP in cerebellum by intrastriatal D-Ala2-met-enkephalinamide.
D000818:Animals; D002375:Catalepsy / Q000139:chemically induced; D002531:Cerebellum / Q000187:drug effects / Q000378:metabolism*; D003342:Corpus Striatum; D006152:Cyclic GMP / Q000378:metabolism*; D004723:Endorphins / Q000494:pharmacology*; D004745:Enkephalins / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D006801:Humans; D007267:Injections; D008297:Male; D009271:Naltrexone / Q000494:pharmacology; D051381:Rats
D004723:Endorphins; D004745:Enkephalins; D009271:Naltrexone; D006152:Cyclic GMP